Chandra Bhagat Pharma Limited (CBPL.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-988.0%

-₹533.33

vs ₹60.06 price

Levered DCF

₹277.09

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

2.14

Grey zone

Rating

B+

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	7.57×	52.61×	51.6×	113.33×	128.3×	544×	247.27×	81.44×
P/B	0.7×	1.51×	2.72×	3.73×	3.85×	3.97×	3.03×	3.88×
P/S	0.2×	0.52×	0.36×	0.86×	1.09×	1.45×	0.83×	0.53×
EV / EBITDA	5.11×	21.03×	24.75×	33.39×	28.67×	32.81×	32.82×	19.17×
Gross margin	19.5%	15.5%	6.4%	10.8%	13.4%	15.4%	8.7%	13.0%
Operating margin	2.4%	-2.8%	5.0%	3.3%	5.7%	5.7%	3.5%	4.2%
Net margin	2.6%	1.0%	0.7%	0.8%	0.8%	0.3%	0.3%	0.6%
Current ratio	1.5×	1.41×	1.38×	2.16×	1.86×	2.13×	2.14×	1.55×
Debt / equity	0.5×	0.7×	0.57×	0.69×	0.79×	1.05×	1.16×	2.16×
Interest coverage	1.38×	-1.24×	8.07×	1.82×	1.81×	1.13×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	9.2%	2.9%	5.3%	3.3%	3.0%	0.7%	1.2%	4.8%
Return on invested capital	4.1%	-3.5%	14.6%	5.2%	7.8%	3.7%	4.1%	6.9%
Return on assets	3.2%	0.8%	1.5%	1.5%	1.1%	0.3%	0.4%	0.8%
Free cash flow yield	36.0%	-15.3%	4.9%	4.8%	12.0%	8.1%	-9.5%	7.2%
Earnings yield	13.2%	1.9%	1.9%	0.9%	0.8%	0.2%	0.4%	1.2%
Enterprise value	₹364.7M	₹653.3M	₹905M	₹1.2B	₹1.2B	₹1.3B	₹1.1B	₹867.6M
Net debt / EBITDA	1.88×	6.5×	3.14×	3.63×	3.75×	6.27×	9.11×	6.8×
Cash conversion cycle (days)	133	358	79	114	199	216	188	146